Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer

NCT05488626 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Shifting patterns of care for the target population.

Conditions

Stage III Non-small Cell Lung Cancer

Interventions

DEVICE: Adaptive Radiotherapy
DEVICE: Non-Adaptive Radiotherapy
DRUG: Chemotherapy
DRUG: Immunotherapy

Sponsor

Varian, a Siemens Healthineers Company